NVN Liquidation Inc (NOVNQ)
0.00
0.00 (0.00%)
USD |
OTCM |
Apr 30, 16:00
NVN Liquidation Shareholders Equity (Quarterly): -2.828M for March 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2023 | -2.828M |
December 31, 2022 | 4.605M |
September 30, 2022 | 6.76M |
June 30, 2022 | 12.25M |
March 31, 2022 | 5.882M |
December 31, 2021 | 18.32M |
September 30, 2021 | 26.18M |
June 30, 2021 | 32.33M |
March 31, 2021 | 0.85M |
December 31, 2020 | 2.977M |
September 30, 2020 | 7.453M |
June 30, 2020 | -0.037M |
March 31, 2020 | -12.36M |
December 31, 2019 | -22.28M |
September 30, 2019 | -27.60M |
Date | Value |
---|---|
June 30, 2019 | -20.22M |
March 31, 2019 | -2.363M |
December 31, 2018 | 6.438M |
September 30, 2018 | -2.296M |
June 30, 2018 | 4.352M |
March 31, 2018 | 11.38M |
December 31, 2017 | -1.716M |
September 30, 2017 | 5.201M |
June 30, 2017 | 11.74M |
March 31, 2017 | 20.73M |
December 31, 2016 | 31.07M |
September 30, 2016 | 43.41M |
June 30, 2016 | 15.97M |
December 31, 2015 | -60.08M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-27.60M
Minimum
Sep 2019
32.33M
Maximum
Jun 2021
2.017M
Average
3.791M
Median
Shareholders Equity (Quarterly) Benchmarks
Cantabio Pharmaceuticals Inc | -1.889M |
Q BioMed Inc | -6.441M |
Affymax Inc | -- |
Scopus BioPharma Inc | -9.452M |
Statera BioPharma Inc | -10.24M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 79.79M |
Total Liabilities (Quarterly) | 82.62M |